Adherence to Antihypertensive Drugs Assessed by Hyphenated High-Resolution Mass Spectrometry Analysis of Oral Fluids.

adherence arterial hypertension compliance liquid chromatography coupled to high‐resolution mass spectrometry toxicological analyses

Journal

Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524

Informations de publication

Date de publication:
21 07 2020
Historique:
pubmed: 8 7 2020
medline: 12 3 2021
entrez: 8 7 2020
Statut: ppublish

Résumé

Background It is currently unknown if antihypertensive drugs can be monitored in oral fluid (OF) using liquid chromatography coupled to high-resolution mass spectrometry. Methods and Results We assessed adherence using liquid chromatography coupled to high-resolution mass spectrometry in OF, plasma, and urine of 56 consecutive patients with hypertension referred to a tertiary hypertension unit. Of these patients, 59% were completely adherent (all drugs detectable in urine), whereas 29% and 13% were partially adherent (1 drug not detectable in urine) or nonadherent (>1 drug not detectable in urine), respectively. Adherent patients were on fewer antihypertensive drugs (

Identifiants

pubmed: 32633188
doi: 10.1161/JAHA.119.014180
pmc: PMC7660713
doi:

Substances chimiques

Antihypertensive Agents 0

Types de publication

Evaluation Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e014180

Références

Forensic Sci Int. 2005 Jun 10;150(2-3):165-73
pubmed: 15899565
Circulation. 2009 Jun 16;119(23):3028-35
pubmed: 19528344
Hypertension. 2010 Feb;55(2):399-407
pubmed: 20026768
J Am Coll Cardiol. 2014 Mar 4;63(8):834-5
pubmed: 24315901
Anal Chim Acta. 2019 Sep 6;1070:69-79
pubmed: 31103169
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001 Sep;92(3):281-91
pubmed: 11552145
J Hypertens. 2013 Apr;31(4):766-74
pubmed: 23337469
Am J Health Syst Pharm. 2001 Jun 15;58(12):1126-32
pubmed: 11449856
Curr Hypertens Rep. 2016 Dec;18(12):89
pubmed: 27889904
Biochem Pharmacol. 2015 Dec 1;98(3):502-10
pubmed: 26388171
Curr Opin Nephrol Hypertens. 2014 Sep;23(5):439-43
pubmed: 25036746
Heart. 2014 Jun;100(11):855-61
pubmed: 24694797
BMJ. 2008 May 17;336(7653):1114-7
pubmed: 18480115
J Am Heart Assoc. 2020 Jul 21;9(14):e014180
pubmed: 32633188
Br J Clin Pharmacol. 2012 May;73(5):691-705
pubmed: 22486599
Ther Drug Monit. 2004 Apr;26(2):200-5
pubmed: 15228165
Clin Biochem Rev. 2006 Aug;27(3):147-59
pubmed: 17268583
Circulation. 2016 Sep 20;134(12):847-57
pubmed: 27576780
Eur Heart J. 2019 Jul 1;40(25):2070-2085
pubmed: 29992264
J Gen Intern Med. 2010 Apr;25(4):284-90
pubmed: 20131023
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999 Sep;88(3):316-9
pubmed: 10503861
J Anal Toxicol. 2000 Oct;24(7):536-42
pubmed: 11043656
Eur J Heart Fail. 2016 Jun;18(6):672-83
pubmed: 26952245
J Anal Toxicol. 1999 Oct;23(6):452-9
pubmed: 10517550
Arch Intern Med. 2007 Sep 10;167(16):1798-803
pubmed: 17846400
Forensic Sci Int. 2005 Jun 10;150(2-3):119-31
pubmed: 15944052
Hypertension. 2016 Aug;68(2):297-306
pubmed: 27296995
Eur Heart J. 2018 Sep 1;39(33):3021-3104
pubmed: 30165516
Clin Pharmacol Ther. 1974 Dec;16(6):1052-8
pubmed: 4433472
J Hum Hypertens. 2016 Jun;30(6):368-73
pubmed: 26446393
Drug Test Anal. 2019 Jan;11(1):102-111
pubmed: 30011134
Biometrics. 1977 Mar;33(1):159-74
pubmed: 843571
N Engl J Med. 2005 Aug 4;353(5):487-97
pubmed: 16079372
J Hypertens. 2011 Mar;29(3):610-8
pubmed: 21157368

Auteurs

Lucas Lauder (L)

Klinik für Innere Medizin III Kardiologie, Angiologie und Internistische Intensivmedizin Universitätsklinikum des Saarlandes and Saarland University Homburg/Saar Germany.

Sebastian Ewen (S)

Klinik für Innere Medizin III Kardiologie, Angiologie und Internistische Intensivmedizin Universitätsklinikum des Saarlandes and Saarland University Homburg/Saar Germany.

Michael Kunz (M)

Klinik für Innere Medizin III Kardiologie, Angiologie und Internistische Intensivmedizin Universitätsklinikum des Saarlandes and Saarland University Homburg/Saar Germany.

Lilian H J Richter (LHJ)

Department of Experimental and Clinical Toxicology Institute of Experimental and Clinical Pharmacology and Toxicology Center for Molecular Signaling Saarland University Homburg/Saar Germany.

Cathy M Jacobs (CM)

Department of Experimental and Clinical Toxicology Institute of Experimental and Clinical Pharmacology and Toxicology Center for Molecular Signaling Saarland University Homburg/Saar Germany.

Ingrid Kindermann (I)

Klinik für Innere Medizin III Kardiologie, Angiologie und Internistische Intensivmedizin Universitätsklinikum des Saarlandes and Saarland University Homburg/Saar Germany.

Michael Böhm (M)

Klinik für Innere Medizin III Kardiologie, Angiologie und Internistische Intensivmedizin Universitätsklinikum des Saarlandes and Saarland University Homburg/Saar Germany.

Markus R Meyer (MR)

Department of Experimental and Clinical Toxicology Institute of Experimental and Clinical Pharmacology and Toxicology Center for Molecular Signaling Saarland University Homburg/Saar Germany.

Felix Mahfoud (F)

Klinik für Innere Medizin III Kardiologie, Angiologie und Internistische Intensivmedizin Universitätsklinikum des Saarlandes and Saarland University Homburg/Saar Germany.
Institute for Medical Engineering and Science MIT Cambridge MA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH